Evergreen Capital Management LLC lifted its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report) by 5.4% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 3,143 shares of the company’s stock after acquiring an additional 160 shares during the quarter. Evergreen Capital Management LLC’s holdings in Prestige Consumer Healthcare were worth $216,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. Norges Bank acquired a new position in Prestige Consumer Healthcare during the fourth quarter worth $27,739,000. UBS Group AG lifted its stake in Prestige Consumer Healthcare by 377.6% during the 4th quarter. UBS Group AG now owns 131,382 shares of the company’s stock worth $8,043,000 after acquiring an additional 103,872 shares in the last quarter. Franklin Resources Inc. boosted its holdings in Prestige Consumer Healthcare by 9.6% during the 4th quarter. Franklin Resources Inc. now owns 20,057 shares of the company’s stock valued at $1,228,000 after acquiring an additional 1,764 shares during the period. Hsbc Holdings PLC grew its position in Prestige Consumer Healthcare by 8.9% in the 4th quarter. Hsbc Holdings PLC now owns 24,050 shares of the company’s stock valued at $1,469,000 after acquiring an additional 1,975 shares in the last quarter. Finally, Parallel Advisors LLC increased its stake in Prestige Consumer Healthcare by 42.5% during the fourth quarter. Parallel Advisors LLC now owns 714 shares of the company’s stock worth $44,000 after purchasing an additional 213 shares during the period. Hedge funds and other institutional investors own 99.95% of the company’s stock.
Prestige Consumer Healthcare Stock Down 0.0 %
Shares of Prestige Consumer Healthcare stock opened at $71.32 on Friday. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. Prestige Consumer Healthcare Inc. has a 52-week low of $56.34 and a 52-week high of $75.80. The company has a market capitalization of $3.53 billion, a P/E ratio of 17.10, a P/E/G ratio of 2.01 and a beta of 0.48. The company has a 50 day moving average of $71.21 and a 200 day moving average of $69.63.
Analyst Upgrades and Downgrades
PBH has been the subject of several recent research reports. Jefferies Financial Group reissued a “hold” rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson raised their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, August 28th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.20.
Get Our Latest Stock Report on Prestige Consumer Healthcare
Prestige Consumer Healthcare Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Recommended Stories
- Five stocks we like better than Prestige Consumer Healthcare
- The 3 Best Blue-Chip Stocks to Buy Now
- CarMax’s Impressive Rally: What Investors Should Watch Next
- What is the FTSE 100 index?
- MarketBeat Week in Review – 9/23 – 9/27
- Golden Cross Stocks: Pattern, Examples and Charts
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report).
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.